These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3001155)

  • 61. Update: evaluation of human T-lymphotropic virus. Type III/lymphadenopathy-associated virus infection in health-care personnel--United States. Centers for Disease Control.
    Conn Med; 1985 Nov; 49(11):772. PubMed ID: 2998701
    [No Abstract]   [Full Text] [Related]  

  • 62. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
    Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
    Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Apparent transmission of human T-cell leukemia virus type III to a heterosexual woman with the acquired immunodeficiency syndrome.
    Groopman JE; Sarngadharan MG; Salahuddin SZ; Buxbaum R; Huberman MS; Kinniburgh J; Sliski A; McLane MF; Essex M; Gallo RC
    Ann Intern Med; 1985 Jan; 102(1):63-6. PubMed ID: 2981497
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The first decade of human retroviruses: a nomenclature for the clinician.
    Lucey DR
    Mil Med; 1991 Oct; 156(10):555-7. PubMed ID: 1660967
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human retroviruses and neoplastic disease.
    Kaplan MH
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S400-6. PubMed ID: 7903870
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HTLV-I infection and schizophrenia.
    Mattock C; Parker NE
    Lancet; 1985 Oct; 2(8461):945. PubMed ID: 2865439
    [No Abstract]   [Full Text] [Related]  

  • 67. A classification of HTLV-III infection based on 75 cases seen in a suburban community.
    Kaplan MH; Pahwa SG; Popovic M; Sarngadharan MG; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4655s-4658s. PubMed ID: 2990703
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical and immunological findings in HTLV-III infection.
    Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
    Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
    Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
    Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rising prevalence of human T-lymphotropic virus type III (HTLV-III) infection in homosexual men in London.
    Carne CA; Weller IV; Sutherland S; Cheingsong-Popov R; Ferns RB; Williams P; Mindel A; Tedder R; Adler MW
    Lancet; 1985 Jun; 1(8440):1261-2. PubMed ID: 2860454
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Early warning skin signs in AIDS and persistent generalized lymphadenopathy.
    Muhlemann MF; Anderson MG; Paradinas FJ; Key PR; Dawson SG; Evans BA; Murray-Lyon IM; Cream JJ
    Br J Dermatol; 1986 Apr; 114(4):419-24. PubMed ID: 3008802
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Granuloma annulare-like eruption due to chronic Epstein-Barr virus infection.
    Spencer SA; Fenske NA; Espinoza CG; Hamill JR; Cohen LE; Espinoza LR
    Arch Dermatol; 1988 Feb; 124(2):250-5. PubMed ID: 2829748
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
    J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reactivation of congenital cytomegalic inclusion disease in an infant with HTLV-III associated immunodeficiency: a CT-pathologic correlation.
    Post MJ; Curless RG; Gregorios JB; Scott GB; Sheldon JJ
    J Comput Assist Tomogr; 1986; 10(3):533-6. PubMed ID: 3009568
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [AIDS--general characteristics and new clues in the studies of etiopathogenesis of the syndrome--the role of HTLV].
    Jonderko K
    Wiad Lek; 1985 Aug; 38(15):1061-6. PubMed ID: 3000090
    [No Abstract]   [Full Text] [Related]  

  • 76. Human T-cell growth factor (interleukin 2) and gamma-interferon genes: expression in human T-lymphotropic virus type III- and type I-infected cells.
    Arya SK; Gallo RC
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8691-5. PubMed ID: 3001715
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.
    Ludlam CA; Tucker J; Steel CM; Tedder RS; Cheingsong-Popov R; Weiss RA; McClelland DB; Philp I; Prescott RJ
    Lancet; 1985 Aug; 2(8449):233-6. PubMed ID: 2862416
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City.
    Stevens CE; Taylor PE; Zang EA; Morrison JM; Harley EJ; Rodriguez de Cordoba S; Bacino C; Ting RC; Bodner AJ; Sarngadharan MG
    JAMA; 1986 Apr; 255(16):2167-72. PubMed ID: 3007789
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Primary human T-lymphotropic virus type III infection.
    Ho DD; Sarngadharan MG; Resnick L; Dimarzoveronese F; Rota TR; Hirsch MS
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):880-3. PubMed ID: 2998251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.